Skip to content
Menu

Jinxin Technology Holding Company NAMI

Full chart Compare
Set alert

Price alert · NAMI

All alert types
1.71 USD +0.09 (+5.56%)

Regular-session close

1.73 +0.02 +1.17%

After hours · Nov 13, 4:00 PM ET

1.58 Day range 1.72
1.51 52-week range 26.75
YTD
-91.05%
1 year
-90.14%

Fundamental scorecard

4 of 25 checks passed on NAMI’s reported financials

Value: 0/5ValueGrowth: 1/5GrowthProfitability: 0/5ProfitabilityFinancial health: 3/5HealthDividend: 0/5Dividend

4of 25 checks passed

  • Value 0 of 5
  • Growth 1 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Value 0 of 5

  • Failed:P/E below its own 5-year median No profit over FY 2025, so no P/E.
  • Failed:P/E under 20 No profit over FY 2025, so no P/E.
  • No data:Price to sales below its own 5-year median Price to sales 0.1. Not enough data to decide.
  • No data:Price to book below its own 5-year median Price to book 0.6. Not enough data to decide.
  • Failed:Free cash flow yield above 4% Free cash flow of -25.4M is -57.5% of the market value.

Growth 1 of 5

  • Passed:Revenue grew over the last year Revenue of 413M is +1.6% on the year before.
  • No data:Revenue grew more than 5% a year over five years Not enough data to decide.
  • Failed:Earnings per share grew over the last year EPS -31.50 against 18.00 in the year before.
  • No data:Earnings per share grew more than 5% a year over five years Not enough data to decide.
  • Failed:Analysts expect higher earnings per share over the next year The average forward estimate is -100.0% on the last 12 months.

Profitability 0 of 5

  • Failed:Profitable over the last year Net income of -94.3M over FY 2025.
  • Failed:Profitable in each of the last five fiscal years A profit in 3 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Return on equity of -89.9%.
  • Failed:Net margin above its 5-year average Net margin of -22.8% against a 5-year average of -1.9%.
  • Failed:Free cash flow is at least 80% of net income No profit over FY 2025 to compare with.

Financial health 3 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 122M against short-term liabilities of 81.5M.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 122M against long-term liabilities of 2.70M.
  • Passed:Net debt under 40% of equity More cash than debt: 58.6M of cash against 13.6M of debt.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of -24.6M is -180.3% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is -2944.3 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Financial position

What NAMI owns and owes, as of Jun 30, 2026

Short term and long term

Balance sheet · 187M of assets

Debt, equity and cash by year

Now: 45.0M more cash than debt

  • Equity
  • Debt
  • Cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings, in its reporting currency.

Cash flow and returns

How NAMI’s profit turns into cash, and what its capital earns

From profit to free cash flow · FY 2025

Returns on capital · FY 2025

  • Benchmark 15%

    -89.9%

    Return on equity

    Below the 15% mark · Profit per dollar of shareholders’ equity

  • Benchmark 5%

    -43.8%

    Return on assets

    Below the 5% mark · Profit per dollar of everything it owns

  • Benchmark 10%

    -89.1%

    Return on capital employed

    Below the 10% mark · Operating profit per dollar of long-term capital

From the company’s SEC filings, in its reporting currency. The tick on each dial is a common rule-of-thumb level, not a target.

Financial health

Altman Z-Score

-1.13 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -5.6×
FY 2021: -230×FY 2022: 384×FY 2023: 289×FY 2024: 947×FY 2025: -5.6×
FY 2021 5y median 289× FY 2025
P/S 1.2×
FY 2021: 73.6×FY 2022: 83.9×FY 2023: 53.7×FY 2024: 51.6×FY 2025: 1.2×
FY 2021 5y median 53.7× FY 2025
P/B 6.2×
FY 2021: -70.3×FY 2022: -93.0×FY 2023: -143×FY 2024: 159×FY 2025: 6.2×
FY 2021 5y median -70.3× FY 2025
P/FCF -14.6×
FY 2021: -331×FY 2022: 838×FY 2023: 468×FY 2024: -587×FY 2025: -14.6×
FY 2021 5y median -14.6× FY 2025
EV/EBITDA -7.6×
FY 2021: -269×FY 2022: 297×FY 2023: 211×FY 2024: 347×FY 2025: -7.6×
FY 2021 5y median 211× FY 2025
EV/Sales 1.1×
FY 2021: 73.4×FY 2022: 83.7×FY 2023: 53.5×FY 2024: 51.4×FY 2025: 1.1×
FY 2021 5y median 53.5× FY 2025
FCF Yield -6.8%
FY 2021: -0.3%FY 2022: 0.1%FY 2023: 0.2%FY 2024: -0.2%FY 2025: -6.8%
FY 2021 5y median -0.2% FY 2025

Profitability

Gross Margin 11.0%
FY 2021: 31.6%FY 2022: 41.1%FY 2023: 42.1%FY 2024: 28.8%FY 2025: 11.0%
FY 2021 5y median 31.6% FY 2025
Operating Margin -24.4%
FY 2021: -28.3%FY 2022: 18.5%FY 2023: 21.1%FY 2024: 6.7%FY 2025: -24.4%
FY 2021 5y median 6.7% FY 2025
Net Margin -22.8%
FY 2021: -32.3%FY 2022: 22.3%FY 2023: 18.6%FY 2024: 5.0%FY 2025: -22.8%
FY 2021 5y median 5.0% FY 2025
ROE -112.5%
FY 2021: 30.8%FY 2022: -24.7%FY 2023: -49.4%FY 2024: 15.4%FY 2025: -112.5%
FY 2021 5y median -24.7% FY 2025
ROIC -76.6%
FY 2021: 783.2%FY 2022: 93.5%FY 2023: 62.4%FY 2024: 15.8%FY 2025: -76.6%
FY 2021 5y median 62.4% FY 2025
ROA -49.1%
FY 2021: -81.8%FY 2022: 43.5%FY 2023: 40.1%FY 2024: 8.3%FY 2025: -49.1%
FY 2021 5y median 8.3% FY 2025

Growth (YoY)

Revenue 1.6%
FY 2021: 0.0%FY 2022: -4.7%FY 2023: 60.6%FY 2024: 7.0%FY 2025: 1.6%
FY 2021 FY 2025
Operating Income -471.9%
FY 2021: 0.0%FY 2022: 162.2%FY 2023: 82.9%FY 2024: -66.1%FY 2025: -471.9%
FY 2021 FY 2025
EPS (diluted) -3398.6%
FY 2021: 0.0%FY 2022: 165.2%FY 2023: 36.4%FY 2024: -73.3%FY 2025: -3398.6%
FY 2021 FY 2025
Free Cash Flow 1.0%
FY 2021: 0.0%FY 2022: 142.9%FY 2023: 84.1%FY 2024: -182.0%FY 2025: 1.0%
FY 2021 FY 2025

Financial Health

Current Ratio 1.5×
FY 2021: 0.7×FY 2022: 1.2×FY 2023: 2.9×FY 2024: 2.2×FY 2025: 1.5×
FY 2021 5y median 1.5× FY 2025
Quick Ratio 1.5×
FY 2021: 0.7×FY 2022: 1.2×FY 2023: 2.9×FY 2024: 2.2×FY 2025: 1.5×
FY 2021 5y median 1.5× FY 2025
Debt / Equity 0.2×
FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.1×FY 2024: 0.0×FY 2025: 0.2×
FY 2021 5y median -0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2021: 0.7×FY 2022: -0.7×FY 2023: -0.7×FY 2024: -1.4×FY 2025: 0.7×
FY 2021 5y median -0.7× FY 2025
Interest Coverage -3151×
FY 2021: -314×FY 2022: 217×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -3151×
FY 2021 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31